Note 11 - License, Research and Collaboration Agreements (Details Textual) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | |
---|---|---|---|
Nov. 30, 2018 |
Mar. 31, 2023 |
Jun. 30, 2023 |
|
ABL Bio Agreement [Member] | |||
Upfront Payment | $ 5,000 | ||
Development Milestone Payment | 6,000 | ||
Maximum Development and Regulatory Milestone Payments | 96,000 | ||
ABL Bio Agreement [Member] | Oncology [Member] | |||
Maximum Commercial Milestone Payments and Royalties | 303,000 | ||
ABL Bio Agreement [Member] | Ophthalmology [Member] | |||
Maximum Development and Regulatory Milestone Payments | 75,000 | ||
Maximum Commercial Milestone Payments and Royalties | $ 110,000 | ||
Adimab Agreement [Member] | |||
Milestone Payments Paid | $ 0 | ||
Milestone Payment Obligation | $ 2,000 |